The KDM1A gene helps control when other genes switch on and off, especially during early brain and body development. If it does not work properly, development can be affected, and some people have delayed speech and learning, low muscle tone, movement differences, or seizures. The protein made by this gene helps your cells keep growth and development on a coordinated path. Pathogenic variants in the KDM1A gene are linked to a rare developmental condition that is usually identified through genetic testing.
What is a gene?
Genes are sections of DNA that provide cells with instructions to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
KDM1AGene function
What if the gene works
The KDM1A gene helps cells switch other genes on and off at the right time. This supports early development and the normal function of the brain and other tissues.
Risk
What if the gene does not work
Variants in the KDM1A gene are linked to a neurodevelopmental condition that often includes developmental delay, speech and learning difficulties, and low muscle tone. Effects can range from milder to severe, influencing when features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No KDM1A-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the KDM1A gene. Research is exploring drugs that block the KDM1A protein, mainly in cancer, but this does not currently guide treatment for inherited KDM1A-related conditions.
Conditions associated with KDM1A
Gene function
What if the gene works
Your cells use the KDM1A gene to manage when many other genes are active or quiet. This helps growth and day to day cell work stay coordinated. Understanding how the KDM1A gene works in your cells makes it easier to see how cells keep the right instructions available at the right time.
The KDM1A gene helps cells adjust small chemical marks on DNA packaging proteins. This helps turn groups of genes up, down, or off at the right time.
By changing how tightly DNA is packaged, the KDM1A gene helps control which instructions are easy for a cell to read. This keeps gene use more organized and better matched to the cell's current job.
During growth and development, the KDM1A gene helps cells keep the right pattern of gene activity for their role. It also supports the gradual shift from early cells to more specialized cell types.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the KDM1A gene alter the protein's shape, stability, or binding to partner proteins, which can reduce its ability to remove chemical tags from histones. In practice, how KDM1A gene variants affect protein function often means weaker control of when other genes are turned on or off during development. Some variants are milder and leave partial activity, while more severe variants disrupt critical regions more strongly. This can be linked to earlier or more noticeable developmental features.
How variants are linked to conditions
Pathogenic variants in the KDM1A gene cause a rare condition often described as KDM1A-related developmental delay. Many people with this diagnosis have delayed speech and learning, low muscle tone, and distinctive facial features, and some also have growth, feeding, or behavior differences. Symptoms can vary from person to person, but a confirmed pathogenic variant in the KDM1A gene can establish the diagnosis.
A variant is not necessarily a diagnosis
Variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the KDM1A gene. In families with a disease-causing KDM1A change, risk is mainly shaped by whether that change is present rather than by lifestyle or common environmental factors.
Inheritance of KDM1A variants
KDM1A-related conditions are inherited in an autosomal dominant pattern. This means one altered copy of the KDM1A gene can be enough to cause the condition, so if a parent carries the variant, each child has a 50% chance of inheriting it. In many families, though, how KDM1A variants are inherited reflects a new (de novo) variant that started in the child and was not passed down from either parent.
What does my KDM1A result mean for my family?
For KDM1A, the main known condition is usually passed in a dominant way, so a parent with the same gene change can pass it to a child. In many families, though, the change happens for the first time in the affected child and is not found in either parent. Close relatives may sometimes choose to ask about testing if there is a family history of similar developmental or muscle tone concerns.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the KDM1A gene usually uses a blood or saliva sample to look for variants through gene panel, exome, or genome sequencing. If you want to know how genetic testing finds KDM1A variants, the lab reads the gene’s DNA code and compares it with the usual sequence to identify changes.
When should I consider getting a genetic test?
Genetic testing for the KDM1A gene may be considered if a child has unexplained developmental delay, speech delay, learning problems, low muscle tone, or seizures, especially when several of these happen together. It can also be helpful when a close family member has a known KDM1A gene change or a similar pattern of symptoms.
A genetic result is only one part of your health story
A genetic result can give helpful insight, but how much it reveals varies based on the condition and the type of variant involved. Over time, the way the body works is also shaped by factors such as age, environment, lifestyle, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it into tissues, or responds to its effects. This is a common reason why the same medication may work well for one person, help less in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It looks at the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KDM1A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general questions about medicines or side effects are best discussed with your doctor. KDM1A is being studied in cancer research because drugs that block its activity may affect how some tumors respond, but this has not led to standard prescribing guidance.
History
The KDM1A gene became historically important in the early 2000s, when researchers showed that methyl marks on histones were not fixed after all. This finding changed a long held view in biology and opened a new chapter in epigenetics, the study of how genes are turned on and off. Building on this early work, scientists uncovered more about the gene and linked it to wider questions about development, cancer, and inherited conditions. The gene was first widely known in research under another name, LSD1, before KDM1A became the standard gene symbol. Over time, descriptions became more precise. Today, the KDM1A gene is remembered as part of a turning point in how scientists think about gene regulation.